Search research articles
Contact Us
Filters
Showing results (111-120 of 156) with videos related to
Page
of 16
Sort By:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
October 1, 2022
Global frequency and epidemiological profile of electronic cigarette users: a systematic review
Beatriz Nascimento Figueiredo Lebre Martins, Ana Gabriela Costa Normando, Carla Isabelly Rodrigues-Fernandes, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 25, 2015
Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis
Luciana Audi de Castroneves, Marcelo Vailati Negrão, Ricardo Miguel Costa de Freitas, et al.
American Journal of Cancer Research
|
January 8, 2024
Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition
Luan César Silva, Amanda Almeida Leite, Gabriell Bonifácio Borgato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2022
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
Gilberto de Castro, Iveta Kudaba, Yi-Long Wu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 29, 2021
Correction to: Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy
Karina Morais Faria, Wagner Gomes-Silva, Elisa Kauark-Fontes, et al.
Ecancermedicalscience
|
September 29, 2017
Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
Juliana Florinda de M Rêgo, Raphael Salles Scortegagna de Medeiros, Maria Ignez Braghiroli, et al.
Clinics (Sao Paulo, Brazil)
|
July 5, 2012
Prophylaxis of fungal infections in transplant patients
Edson Abdala, Sílvia Figueiredo Costa, Tania Mara Varejão Strabelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 23, 2020
Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy
Karina Morais Faria, Wagner Gomes-Silva, Elisa Kauark-Fontes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2025
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Makoto Tahara, Richard Greil, Danny Rischin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2022
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC
Gilberto de Castro, Naiyer A Rizvi, Peter Schmid, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 156) with videos related to
Sort By:
Page
of 16
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
October 1, 2022
Global frequency and epidemiological profile of electronic cigarette users: a systematic review
Beatriz Nascimento Figueiredo Lebre Martins, Ana Gabriela Costa Normando, Carla Isabelly Rodrigues-Fernandes, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 25, 2015
Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis
Luciana Audi de Castroneves, Marcelo Vailati Negrão, Ricardo Miguel Costa de Freitas, et al.
American Journal of Cancer Research
|
January 8, 2024
Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition
Luan César Silva, Amanda Almeida Leite, Gabriell Bonifácio Borgato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2022
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
Gilberto de Castro, Iveta Kudaba, Yi-Long Wu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 29, 2021
Correction to: Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy
Karina Morais Faria, Wagner Gomes-Silva, Elisa Kauark-Fontes, et al.
Ecancermedicalscience
|
September 29, 2017
Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
Juliana Florinda de M Rêgo, Raphael Salles Scortegagna de Medeiros, Maria Ignez Braghiroli, et al.
Clinics (Sao Paulo, Brazil)
|
July 5, 2012
Prophylaxis of fungal infections in transplant patients
Edson Abdala, Sílvia Figueiredo Costa, Tania Mara Varejão Strabelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 23, 2020
Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy
Karina Morais Faria, Wagner Gomes-Silva, Elisa Kauark-Fontes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2025
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Makoto Tahara, Richard Greil, Danny Rischin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2022
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC
Gilberto de Castro, Naiyer A Rizvi, Peter Schmid, et al.
Page
of 16